pegylated antianji peptide (Jiangsu Aotaixin Biomedical Technology/Nanjing Anji Biotech/China Pharmaceutical University)

N/A

Report date: 2025/03/20 15:27:22

Base Information

Drug Namepegylated antianji peptide (Jiangsu Aotaixin Biomedical Technology/Nanjing Anji Biotech/China Pharmaceutical University)
Drug Alias NamemPEG-SC20 k-HM-3pegantiangiotide
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Aotexin Biomedical Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Aotexin Biomedical Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A